Cardio Diagnostics Holdings Inc. - Common stock (CDIO)
1.1200-0.1400(-11.11%)
Cardio Diagnostics Holdings Inc. is a healthcare company focused on advancing personalized cardiovascular medicine through innovative diagnostic solutions. The company develops and commercializes cutting-edge technologies aimed at improving heart health management by offering comprehensive insights into individual cardiovascular risks. By leveraging advanced analytics and proprietary testing methodologies, Cardio Diagnostics seeks to empower healthcare providers and patients with actionable data to enhance decision-making and optimize treatment strategies for cardiovascular diseases. Their mission is to enhance patient outcomes and revolutionize the way cardiovascular health is understood and managed.
CDIO stock results show that Cardio Diagnostics Hldgs beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
CDIO stock results show that Cardio Diagnostics Hldgs missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Mayumi Kitakata, a Tokyo resident, uses the AI-driven app CatsMe! to monitor the health of her aging cat, reflecting the growing trend of AI in pet healthcare.
BlackRock (NYSE: BLK) to acquire full ownership of SpiderRock Advisors, expanding offerings in customized option overlay strategies for U.S. wealth market.
Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.